دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Rucaparib for BRCA1/2-mutated pretreated ovarian cancer: reflections from the ARIEL4 trial
Dearbhaile MO'Donnella
De-escalating elective nodal irradiation for nasopharyngeal carcinoma
Jacob AMilleraBeth MBeadleaMichael FGensheimeraQuynh-ThuLea
Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancer
ShankarSivaabMuhammadAliabMathiasGuckenbergerc
ARCS-M: forging progress from this negative trial in malignant pleural mesothelioma
Marjorie GZaudereraMichaelOffina
Improving cancer care for people with disabilities
CherylReevesaDavidCollingridgea
Al-Nawati tragedy: a 16-year-old patient with leukaemia and no access to cancer care
FatenAmera
Quality of data from cancer registries in the Eastern Mediterranean region
EmanAlkhalawiaArianaZnaorbAli SaeedAl-Zahranic
Pulling the investment levers on implementation research in oncology
ParthaBasuaAndre LCarvalhoaMaribelAlmonteaVéroniqueChajèsaElisabeteWeiderpassa
Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials
AlessandroOttaianoaMariachiaraSantorsolaaFedericaCaracòaMicheleCaragliabGuglielmoNastia
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
Joe YChangaVivekVermaaJames WWelshaSilvia CFormentib
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
MariaOchoa-de-OlzaabJeanBourhiscGeorgeCoukosabFernanda GHerreraabc
Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC
NanBiaYuWangaLuhuaWangb
Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC – Author's reply
Yi-LongWua
Consequences of US FDA approval decisions in high-income countries
KristinaJeneia
Decentralisation to improve cancer services in DR Congo
ManjulikaDas
Consequences of the crisis in Ukraine on cancer care
Talha KhanBurki
Qatar Red Crescent Society provides cancer drugs to the Palestinian Ministry of Health
SharmilaDevi
2-week cancer target to be scrapped in England in overhaul of NHS standards
EmmaWilkinson
SSO 2022 International Conference on Surgical Cancer Care
MárciaCosta
Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement
RichardSullivanaGrantLewisonaJulieTorodeaPeter TKinghambMurrayBrennanbLawrence NShulmancMarkLawlerdAjayAggarwalaeJulieGralowf
ICGC-ARGO precision medicine: targeted therapy according to longitudinal assessment of tumour heterogeneity in colorectal cancer
DaisukeKotaniaYoshiakiNakamuraabTakaoFujisawabcHideakiBandoabNaoyaSakamotodAmber LJohnseKeunchilParkf
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
RebeccaKristeleitMDaAllaLisyanskayaMDbAlexanderFedenkoMDcMikhailDvorkinMDdAndreia Cristinade MeloMDeProfYaroslavShparykMDfProfIrinaRakhmatullinaMDghProfIgorBondarenkoMDiProfNicolettaColomboMDjValentynSvintsitskiyMDkLucianoBielaMDlMarinaNechaevaMDmProfDomenicaLorussoMDnProfGiovanniScambiaMDoDavidCibulaMDpProfRóbertPókaMDqAnaOakninMDrTamarSafraMDs…ProfAmit MOzaMDz
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial
ProfLing-LongTanga*†Cheng-LongHuangMDa*ProfNingZhangMDd*ProfWeiJiangMDe*Yi-ShanWuMDb*ProfShao HuiHuangMDfProfYan-PingMaoMDaProfQingLiuPhDcJi-BinLiPhDcProfShao-QiangLiangMDdGuan-JieQinMDeProfWei-HanHuMDaProfYingSunMDaProfFang-YunXieMDaLeiChenMDa†Guan-QunZhouMDa†ProfJunMaMDaâ€
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
JulieDelyonPhDacLucieBiardPhDbgMarionRenaudMSccProfMatthieuResche-RigonPhDbgProfJérômeLe GoffPhDahProfStéphaneDallePhDiValentineHeidelbergerMDjLaetitiaDa MedaMSccLaurieToullecMDadProfGuislaineCarcelainPhDakProfSamiaMourahPhDaeProfSophieCaillat-ZucmanPhDadVincentAllainMDadProfMaximeBattistellaPhDafProfCélesteLebbePhDac
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial
ProfDavidDearnaleyFRCRacVictoriaHinderBScbAdhamHijabMDcGailHoranFRCRdNarayananSrihariFRCRePhilipRichFRCRfProfJ GraemeHoustonMDgAnn MHenryMDhStephanieGibbsFRCRiRamVenkitaramanFRCRjClareCruickshankBScbShamaHassanMScbAlecMinersPhDkProfMalcolmMasonMDlIanPedleyFRCRmProfHeatherPayneFRCRnSusannahBrockFRCRoRobertWadeFRCRp…ProfEmmaHallPhDbâ€
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
ProfKerstin NVokingerMDabThomas JHwangABbDavid LCarlBAaYannicLaubeBAaProfWolf-DieterLudwigMDcProfHuseyinNaciPhDdProfAaron SKesselheimMDb
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
Darren Jun HaoTana*Cheng HanNga*Snow YunniLinaXin HuiPanaPhoebeTayaWen HuiLimaMargaretTengMBBSbNicholasSynMBBSaGraceLimcJie NingYongaJingxuanQuekaJielingXiaoaProfYock YoungDanMBBSabMohammad ShadabSiddiquiMDdProfArun JSanyalMDdMark DMuthiahMBBSabeProfRohitLoombaMDf†Daniel QHuangMBBSabefâ€
Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index
ProfGustavo AVianiPhDaAndre GGouveiaMDcVanessa FBrattiMPHdProfJuliana FPavoniPhDbProfRichardSullivanPhDhWilma MHopmanMAdChristopher MBoothMDefAjayAggarwalMScijTimothy PHannaPhDefFabio YMoraesPhDfg
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
ProfHedy LKindlerMDaProfSilviaNovelloMDbAlessandraBearzMDcGiovanni LCeresoliMDdProfJoachim G J VAertsMDeProfJamesSpicerPhDfPaulTaylorMB ChBgProfKristiaanNackaertsMDhAlastairGreystokeMBChBiRossJennensMBBSjLuanaCalabròMDkJacobus ABurgersMDlProfArmandoSantoroMDmnSusanaCedrésMDoPiotrSerwatowskiMDpSantiagoPonceMDpProfJan PVan MeerbeeckMDqProfAnna KNowakMBBSrs…ProfDean AFennellPhDab
Cancer detection, diagnosis, and treatment for adults with disabilities
Lisa IIezzoniab
Cancer treatment and decision making in individuals with intellectual disabilities: a scoping literature review
Anne JBoonmanMScaMaartenCuypersPhDaProfGeraline LLeusinkMDaJennekenNaaldenbergPhDaProfHaiko JBloemendalMDb
Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Jordan GillelandMarchakPhDab*SalomeChristenMAc*Renée LMulderPhDdKatjaBaustDipl-PsycheJohanna M CBlomPhDfTara MBrinkmanPhDgIrisElensjErikaHarjuPhDbProfNina SKadan-LottickMDlJoel W TKhorMRCPsychmJurgenLemierePhDikChristopher JRecklitisPhDnoProfClaire EWakefieldPhDpqLoriWienerPhDrProfLouis SConstineMDsProfMelissa MHudsonMDghProfLeontien C MKremerPhDdProfRoderickSkinnerPhDt…ProfGiselaMichelPhDcâ€
Radiation recall after COVID-19 infection
Richard BlakeRossaRachel ARabinovitcha
